Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure.
D000284:Administration, Oral; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D002250:Carbon Radioisotopes; D002845:Chromatography; D003404:Creatinine / Q000378:metabolism; D005260:Female; D006333:Heart Failure / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D007275:Injections, Intravenous; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D011799:Quinazolines / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D013997:Time Factors
D000959:Antihypertensive Agents; D002250:Carbon Radioisotopes; D011799:Quinazolines; D003404:Creatinine